Skip to main content
HARROW, INC. logo

HARROW, INC. — Investor Relations & Filings

Ticker · HROW ISIN · US4158581094 US Manufacturing
Filings indexed 840 across all filing types
Latest filing 2025-10-11 Director's Dealing
Country US United States of America
Listing US HROW

About HARROW, INC.

https://www.harrow.com/

Harrow, Inc. is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic products. The company provides eyecare professionals and their patients with a comprehensive portfolio of innovative, accessible, and affordable solutions designed to enhance patient care and improve vision outcomes. Its offerings include a growing portfolio of branded therapies, essential ophthalmic medications, and specialized compounding services. Harrow focuses on expanding access to high-quality treatments, combining innovation with affordability to redefine eyecare.

Recent filings

Filing Released Lang Actions
3
Director's Dealing
2025-10-11 English
Delisting Announcement 2025
Delisting Announcement
2025-10-10 English
Delisting Announcement 2025
Delisting Announcement
2025-10-08 English
8-K
Regulatory Filings
2025-10-06 English
8-K/A
Regulatory Filings
2025-10-01 English
8-K
Regulatory Filings
2025-09-29 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.